E-Posters - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.05 - NEUROINTERVENTION P2079 - ESOC25-1511 TIROFIBAN BEYOND STENTING: A NEW HORIZON IN MECHANICAL THROMBECTOMY Pablo Abizanda Saro 1 , Luca Lpez Trashorras 1 , Lorena Franco Rubio 1 , Ana Aldaz Burgoa 1 , Nicols Rodrguez Albacete 1 , Patricia Simal Hernndez 1 , Jos Antonio Egido Herrero 1 , Manuel Moreu 2 , Carlos Prez-Garca 2 , Santiago Rosati 2 , Alfonso Lpez-Fras Lpez-Jurado 2 , Carmen Trejo 2 , ngela Huete Schmolling 2 , Carlos Gmez-Escalonilla 1 1 Neurology, Hospital Clnico San Carlos, Madrid, Spain, 2 Neuroradiology, Hospital Clnico San Carlos, Madrid, Spain Background and Aims: Tirofiban is increasingly utilized in endovascular procedures, particularly for large intracranial vessel occlusions requiring stent placement
Understanding the risk of scarring encourages you to take early action when breakouts begin
This is the question almost every first-time patient asks
5-Amino-1MQ in research into adipose tissue metabolism Accelerated fat burning: Inhibition of NNMT leads to a reduction in 1-MNA levels (a product of NNMT activity), which promotes lipolysis the body is more inclined to mobilise fat stores
The primary downstream effect is AMPK activation, which signals cells to shift from glucose storage to fat oxidation
